ARWR:NASDAQ
Arrowhead Pharmaceuticals Inc
$67.56
arrow_upward
+2.70%(+1.78) 1D
Sep 17, 10:16:57 AM GMT-4 · USD
search
All symbols
1D
5D
1M
6M
YTD
1Y
5Y
MAX
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for ARWR...
Open
$68.91
High
$68.91
Low
$67.00
Mkt. cap
9.54B
Avg. vol.
1.47M
Volume
690.52K
52-wk high
$95.49
52-wk low
$29.81
EPS
-$2.24
Beta
1.28
Shares outstanding
141.25M
No. of employees
711
Open
$68.91
High
$68.91
Low
$67.00
Mkt. cap
9.54B
Avg. vol.
1.47M
Volume
690.52K
52-wk high
$95.49
52-wk low
$29.81
EPS
-$2.24
Beta
1.28
Shares outstanding
141.25M
No. of employees
711
News stories
From web sources and news partners
Benzinga
·
20 hours ago
10 Health Care Stocks Whale Activity In Today’s Session
TradingView
·
23 hours ago
ARWR: Pivotal RNAi trial results and new launches set the stage for major growth across multiple indications
Investing.com
·
1 day ago
Arrowhead Pharmaceuticals at H.C. Wainwright: launch and pipeline widen
Benzinga
·
1 day ago
Arrowhead Achieves Clinical Validation for New Drug Platform
Profile
Arrowhead Pharmaceuticals, Inc. is a publicly traded biopharmaceutical company based in Pasadena, California. Arrowhead's products in development act through RNA interference mechanisms of action. The company focuses on treatments for hepatitis B, liver disease associated with alpha 1-antitrypsin deficiency and cardiovascular disease. Wikipedia
About Arrowhead Pharmaceuticals Inc
CEOChristopher Richard Anzalone
Employees711
FoundedJan 1, 2004
HeadquartersPasadena, California, United States
SectorBiotechnology
Websitearrowheadpharma.com